Plasma Norepinephrine Kinetics, Dopamine-β-Hydroxylase, and Chromogranin-A, in Hypothyroid Patients before and following Replacement Therapy*
Abstract
Whether the increased plasma norepinephrine level reported in hypothyroidism is the result of impaired norepinephrine (NE) clearance or increased NE release by nerve terminals is unknown. We, therefore, measured plasma NE levels and clearance in 11 hypothyroid patients before [T4 index, 41.2 +/- 7.7 nmol/L (mean +/- SEM); TSH, 71.4 +/- 23.0 mU/L] and 4 +/- 0.5 months after thyroid replacement (T4 index, 136.4 +/- 24.4 nmol/L; TSH, 3.2 +/- 1.2 mU/L) and in 8 healthy volunteers. Plasma dopamine-beta-hydroxylase and chromogranin-A, which are coreleased with NE by sympathetic nerve endings, were also measured. Plasma NE was higher in the hypothyroid (2.37 +/- 0.24 nmol/L) than in the euthyroid state (1.86 +/- 0.24 nmol/L; P less than 0.02) or in the controls (1.87 +/- 0.27 nmol/L). Plasma clearance of NE, however, was not affected after thyroid replacement (hypothyroid, 2.08 +/- 0.31 L/min; euthyroid, 1.94 +/- 0.21 L/min; controls, 1.86 +/- 0.15 L/min). There was no significant change in plasma dopamine-beta-hydroxylase (hypothyroid, 720 +/- 139 nmol/mL.h; euthyroid, 553 +/- 97 nmol/mL.h) or plasma chromogranin-A (hypothyroid, 48.9 +/- 7.1 ng/mL; euthyroid, 42.9 +/- 5.3 ng/mL) after thyroid replacement. We conclude that the increased plasma NE in hypothyroid patients is not due to a change in plasma clearance, but is more likely secondary to increased NE release.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
O’Connor, D. T., & Deftos, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605013141803 · Cited by 474 · see citing works
Self-citationA sensitive enzymatic assay for dopamine- -hydroxylase.
Molinoff, P. B., Weinshilboum, R. M., & Axelrod, J. (1971) · PubMed · Cited by 456 · see citing works
Bilezikian, J. P., & Loeb, J. N. (1983) · Endocrine Reviews · doi:10.1210/edrv-4-4-378 · Cited by 354 · see citing works
Determination of norepinephrine apparent release rate and clearance in humans
Esler, M., Jackman, G. P., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H., & Korner, P. I. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90371-0 · Cited by 340 · see citing works
Serum Dopamine-Beta-Hydroxylase Activity
Weinshilboum, R. M., & Axelrod, J. (1971) · Circulation Research · doi:10.1161/01.res.28.3.307 · Cited by 325 · see citing works
O’Connor, D. T., & Bernstein, K. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409203111204 · Cited by 228 · see citing works
Self-citationPlasma Noradrenaline and Adrenaline in Patients with Thyrotoxicosis and Myxoedema
Christensen, N. J. (1973) · Clinical Science · doi:10.1042/cs0450163 · Cited by 208 · see citing works
COULOMBE, P., DUSSAULT, J. H., & WALKER, P. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1185 · Cited by 170 · see citing works
Assessment of Sympathetic Nervous Function in Humans from Noradrenaline Plasma Kinetics
Esler, M. (1982) · Clinical Science · doi:10.1042/cs0620247 · Cited by 168 · see citing works
Plasma catecholamines in hypothyroidism and hyperthyroidism
STOFFER, S. S., JIANG, N.-S., GORMAN, C. A., & PIKLER, G. M. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-3-587 · Cited by 137 · see citing works
New perspectives on thyroid hormone, catecholamines, and the heart
Klein, I. L., & Levey, G. S. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90768-x · Cited by 86 · see citing works
Norepinephrine metabolism in humans. Kinetic analysis and model.
Linares, Ó., Jacquez, J. A., Zech, L. A., et al. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113210 · Cited by 72 · see citing works
Thyroid hormone modulation of agonist - beta-adrenergic receptor interactions in the rat heart
Stiles, G. L., & Lefkowitz, R. J. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90595-6 · Cited by 69 · see citing works
Revised Nomenclature for Tests of Thyroid Hormones and Thyroid-Related Proteins in Serum.
Larsen, P. R., Alexander, N. M., CHOPRA, I. J., HAY, I. D., Hershman, J. M., Kaplan, M. M., Mariash, C. N., Nicoloff, J. T., Oppenheimer, J. H., & Solomon, D. H. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-1089 · Cited by 63 · see citing works
Ciaraldi, T. P., & Marinetti, G. V. (1978) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(78)90193-9 · Cited by 57 · see citing works
Evaluation of Adjusted Total Thyroxine (Free Thyroxine Index) as a Measure of Thyroid Function
Stein, R. B., & PRICE, L. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-1-225 · Cited by 41 · see citing works
Catecholamine sensitivity in hyperthyroidism and hypothyroidism.
McDevitt, D., Riddell, J., Hadden, D., & Montgomery, D. A. D. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb00855.x · Cited by 41 · see citing works
Biochemical Quantification of Sympathetic Nervous Activity in Humans Using Radiotracer Methodology
Esler, M., Leonard, P., O’Dea, K., et al. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198200041-00030 · Cited by 35 · see citing works
Ishac, E. J. N., Pennefather, J. N., & Handberg, G. M. (1983) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198305000-00009 · Cited by 32 · see citing works
Serum Dopamine-β-hydroxylase Activity in Thyroid Disorders
Nishizawà, Y., Hamada, N., Fujii, S., et al. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-3-599 · Cited by 32 · see citing works
Manhem, P., Hallengren, B., & Hansson, B. G. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00120.x · Cited by 23 · see citing works
EFFECT OF TREATMENT OF HYPOTHYROIDISM ON CIRCULATORY RESPONSE TO ADRENALINE
Leak, D., & Lew, M. (1963) · Heart · doi:10.1136/hrt.25.1.30 · Cited by 17 · see citing works
The Inverse Relationship between Serum Dopamine-β-Hydroxylase Activity and Thyroid Function*
Stolk, J. M., Hurst, J. H., & NISULA, B. C. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-2-259 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Thermogenic Mechanisms and Their Hormonal Regulation
Silva, J. E. (2006) · Physiological Reviews · doi:10.1152/physrev.00009.2005 · Cited by 687 · see citing works
Thyroid–Adrenergic Interactions: Physiological and Clinical Implications
Silva, J. E., & Bianco, S. D. C. (2008) · Thyroid · doi:10.1089/thy.2007.0252 · Cited by 252 · see citing works
- Authors
- POLIKAR, R., KENNEDY, B., ZIEGLER, M., O'CONNOR, D. T., SMITH, J., & NICOD, P.
- Affiliations
- University of California San Diego Medical Center (US)
- ORCID
- ZIEGLER, MICHAEL
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1990-01
- Volume
- 70
- Issue
- 1
- Pages
- 277-281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2131523884
- Semantic Scholar
- 461bbc521cf4f82e9452389ff17482f92324ae4a
- Cited by
- 40
- References
- 23
- Citations by year
- 2020: 1 · 2019: 2 · 2015: 1 · 2014: 1 · 2013: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01hl035924-06)
- National Heart, Lung, and Blood Institute (HL 35924)
- National Center for Research Resources (MO1 RR00827, M01RR000827)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypothyroidism, plasma norepinephrine, norepinephrine clearance, noradrenaline release, thyroid hormone replacement, dopamine beta-hydroxylase, chromogranin A, sympathetic nervous system, thyroid hormones
- MeSH terms
- Adult, Aged, Chromogranins, Dopamine beta-Hydroxylase, Female, Half-Life, Humans, Hypothyroidism, Male, Metabolic Clearance Rate, Middle Aged, Nerve Endings, Nerve Tissue Proteins, Norepinephrine, Thyrotropin, Thyroxine, Chromogranin A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review